Taylor, S. I., Blau, J. E., & Rother, K. I. (2014). SGLT2-inhibitors Trigger Downstream Mechanisms That May Exert Adverse Effects Upon Bone. Lancet Diabetes Endocrinol.
Citação norma ChicagoTaylor, Simeon I., Jenny E. Blau, and Kristina I. Rother. "SGLT2-inhibitors Trigger Downstream Mechanisms That May Exert Adverse Effects Upon Bone." Lancet Diabetes Endocrinol 2014.
Citação norma MLATaylor, Simeon I., Jenny E. Blau, and Kristina I. Rother. "SGLT2-inhibitors Trigger Downstream Mechanisms That May Exert Adverse Effects Upon Bone." Lancet Diabetes Endocrinol 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.